Skip to main content
OpenTrials
Completed

NCT Number: NCT04413019

Domiciliary Versus Hospital Management of PPROM

This study is designed to compare efficacy & safety of planned domiciliary versus hospital care for women with preterm prelabor rupture of the membranes (PPROM) on fetal, neonatal and maternal outcome.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Faculty of medicine - Ain Shams university

Cairo, 11517, Egypt

About this study

Background: PPROM is encountered in 2.0% to 3.5% of pregnancies. Domiciliary care management is developing more and more in obstetrics, with psychological benefits for patients as well as other financial benefits. Reliable discharge criteria have been mentioned by few studies for patients with PPROM. Studies had shown that domiciliary care management in a context of PPROM did not modify perinatal morbidity and mortality, and allows a prolongation of the latency period. However, eligibility criteria for domiciliary care management were heterogeneous

Aim of The Work: The aim of this study is to compare efficacy & safety of planned domiciliary versus hospital care for women with preterm prelabor rupture of the membranes (PPROM) on fetal, neonatal and maternal outcome.

Patients & Methods: The current trial was conducted at Ain Shams University Maternity Hospital. A total of 3662 pregnant women were recruited from the outpatient clinic & emergency room and included in the study. Then, they were randomized into two groups; group (D) was counseled for home care management, while group (H) was hospitalized. Take-home baby was assessed as a primary outcome and other maternal, fetal & neonatal complications were recorded & moreover latency period, mode of delivery & preference of care were assessed

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

include women with PPROM ≥28 weeks & <37 weeks with no signs of intra-amniotic infection & membranes rupture is confirmed by a sterile speculum examination and decrease amniotic fluid on ultrasound with singleton, viable, cephalic presenting fetus, morphologically normal fetus by ultrasound & reactive fetal heart rate tracing with no evidence of meconium-stained liquor

Exclusion criteria

  • Query PPROM: A history of PPROM with no pooling of amniotic fluid from the cervix on a sterile speculum examination
  • Maternal comorbidities (Diabetes mellitus, hypertension, etc.)
  • Patients with placenta previa
  • Amniotic fluid pocket on ultrasound < 2x2 cm
  • Logistic problems interfering with follow-up
  • Inability to check temperature every six hours, with parameters for notifying their clinician (temperature ≥38°C)
  • Non-Dependable transportation

Treatment and study plan

Clinical follow up

Other

Patients recruited in this study commenced antibiotic treatment according to the recent guidelines :

  • Erythromycin 250 mg 4 times daily for 10 days following the diagnosis of PPROM, or until the women is established labor (whichever sooner)
  • Penicillin may be used in patients who can't tolerate erythromycin
  • In cases of penicillin allergy: Cefazolin 1 g intravenously every 8 hours for 48 hours, followed by cephalexin 500 mg orally four times daily for five days. These drugs provide coverage for both GBS and Escherichia coli, the two major causes of neonatal infection.

Primary outcomes

  1. Take-home baby

    Time frame: 2 years

    this outcome is the best indicator of success of the management plan when the outcome is alive & well baby

Sponsors and collaborators

Lead sponsor

Ahmed Mohammed Selim

Other

Registry information

Official study title

Planned Domiciliary Versus Hospital Care for Women With Preterm Prelabor Rupture of the Membranes (PPROM)

Acronym: PPROM

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jun 2, 2020
Registry last updated
Jan 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.